Valve Leaflet Thrombosis 'Not Stent Thrombosis All Over Again'

ACC Conference Reporter

TCT 2015 | SAN FRANCISCO — The release of data last week showing reduced leaflet mobility in as many as 40% of bioprosthetic aortic valves, apparently due to subclinical thrombosis, doesn't mean a return to the woes around drug-eluting stents in the mid-2000s. Read More >>>

Keywords: Transcatheter Cardiovascular Therapeutics

< Back to Listings